Davis's Drug Guide is a medical reference app for nurses and physicians providing drug monographs, IV calculators, and pill identification tools on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
#15
▲2Medical · grossing
Sentiment
4.8
11k reviews
Nemesis
Drugs.com Medication Guide
The App DNA
What makes this app unique?
Users hire the app to ensure medication safety and clinical accuracy during high-stakes nursing shifts, where reliable, updated dosing data is a professional requirement.
For Nursing students, practicing nurses, physicians, and pharmacists requiring reliable, updated medication reference data.
What does it look like?
Key features
1,700+ entries covering 5,000+ trade and generic medications with safety alerts and REMS data
Integrated tools for calculating drips and dosing directly within the app
Cross-platform access to the database via web browser after app purchase
How much does it cost?
Subscription model anchored at $39.99/year, utilizing a free trial period to convert students and professionals into annual recurring revenue.
Velocity
Maintenance developmentmonetizationperformanceShow more...
The app ships approximately 0.2 releases per week, placing it in the maintenance tier. Development is currently focused on infrastructure, specifically payment process upgrades and regulatory compliance, rather than user-facing features. The latest release continues this trend of technical maintenance. There is no evidence of live-ops activity or significant feature expansion in the observed data.
Who built it?
Unbound Medicine
13+ apps tracked · Medical
DSM-5-TR® Diagnosis Handbook
5-Minute Emergency Medicine
Johns Hopkins Antibiotic Guide
Nursing Central
Oxford Handbook Clinical Med
Oxford Emergency Medicine
Oxford Handbook of Anaesthesia
Oxford General Practice
Oxford Obstetrics & Gynecology
5 Minute Sports Med Consult
Oxford Foundation Programme
Taber's Medical DictionaryUser Sentiment
What do users think recently?
The recent review mood reads mixed. Users appreciate succinct medication monographs provide reliable clinical reference for nursing students and practitioners and integrated dosage and infusion calculators assist with critical medication safety checks, but report subscription and login errors prevent access to paid content across devices.
How are ratings & reviews evolving?
What users say, by theme
- Succinct medication monographs provide reliable clinical reference for nursing students and practitioners
- Integrated dosage and infusion calculators assist with critical medication safety checks
- Subscription and login errors prevent access to paid content across devices
70 of 102 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Davis's Drug Guide - Nurses
How's the Medical market?
Davis's Drug Guide holds the #10 Grossing position in the US Medical category, but the gap between its high utility and the #30-34 rankings in international markets suggests the $39.99/year price point is a barrier to global adoption.
Read the market outlookThe rivals identified
By Drugs.com
With over 36,000 reviews and a massive, established user base, this is the primary market leader for general medication information.
- Provides a comprehensive, free-to-access pill identification tool that integrates directly with medication guides
- Maintains a massive, centralized database that serves as a primary reference for both patients and clinicians
- Offers a broader, consumer-facing utility that captures high-volume search traffic compared to specialized nursing guides
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Davis's Drug Guide - Nurses
Where is it heading?
The clinical reference market is consolidating around high-velocity, multi-surface tools, leaving Davis's Drug Guide exposed due to its rigid subscription-only model and authentication friction. If the team does not solve the cross-platform login issue, the current #10 Grossing rank will likely erode as users migrate to more stable, free-to-access alternatives.
- Persistent authentication failures post-update erode professional trust, which directly suppresses the app's long-term subscription renewal rate.
- The shift to a mandatory subscription model alienates legacy textbook users, accelerating churn among the core nursing student segment.
The SWOT
- Integrated IV calculators function as a daily-use clinical retention loop
- Exclusive DrugGuide.com web access creates a multi-surface professional workflow
- Dark mode implementation would address the #1 UI-specific request for night-shift staff
- License portability across platforms would reduce the high-frequency login complaint
Next best moves
Ship account-based license portability because login errors are the top-cited churn driver → increase retention
+ 1 more prioritized moveThe counter-intuitive read
The #10 Grossing rank is a vulnerability: the app's reliance on a $39.
Read the full takeFeature gaps
Real-time clinical news feed (available in Medscape but absent here) +1
Since the last report: The app has pivoted to a mandatory annual subscription model, which has triggered significant user churn and authentication-related complaints.
Bottom line
Davis's Drug Guide maintains clinical authority through its integrated calculators, but the recurring authentication failures threaten its subscription revenue, so the PM must prioritize account-based license portability to stop the churn of professional users.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated